Vertigo Market Trends, Size, Growth, Opportunities and 2021 Global Forecast Report

MarketReportsOnline.com adds "Global Vertigo Market: Industry Analysis & Outlook (2017-2021)" report to its research store.

PUNE, India, Nov. 30, 2017 /PRNewswire-iReach/ -- MarketReportsOnline.com adds "Global Vertigo Market: Industry Analysis & Outlook (2017-2021)" report to its research store.

Vertigo is a medical condition where a person feels as if they or the objects around them are moving when they are not. Often it feels like a spinning or swaying movement. This may be associated with nausea, vomiting, sweating, or difficulties walking. It is typically worsened when the head is moved.

Complete report on Global Vertigo Market spread across 61 pages with providing 4 company profiles, 10 tables and 28 charts is now available at http://www.marketreportsonline.com/701208.html.

Vertigo is the most common type of dizziness. The causes for vertigo can be divided into two categories: Peripheral and Central. Peripheral is linked to the inner ear whereas central is linked to problems in Central Nervous System.

Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Meniere's disease and Vestibular Schwannoma. Amongst all the stated indication, Meniere's disease represents the largest growth opportunity for the market players with its continuously rising incidence.

Growth of global vertigo market is expected to be driven by factors such as rising incidence and prevalence of peripheral etiologies of vertigo, increasing geriatric population, growing healthcare expenditure and improving disposable income. Further, the market growth could be hindered by side effects of currently prescribed medication, the high cost of treatment and tedious drug approval process. The key trends for the market include extensive research & development and different approaches being adopted by drug manufacturers in order to target vertigo.

Purchase a copy of this "Global Vertigo Market" research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=701208.

A key drug Otividex, which is currently in third phase of clinical trials and is being developed by Otonomy Inc., is discussed in the report. The drug is easier to use and provides a higher and sustained concentration of dexamethasone relative to existing injections. Further, it is anticipated to provide a well-accepted treatment option for Meniere's Disease, if successfully developed.

The report "Global Vertigo Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players involved in the development of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound Pharmaceuticals, Inc. are being profiled along with their key financials and strategies for growth.

Major Points from Table of Contents:

1. Introduction
1.1 Vertigo
1.2 Causes & Types
1.3 Diagnosis & Treatment

2. Global Vertigo Market
2.1 Global Recurrent Vestibular Vertigo Patient Forecast
2.2 Global Treatable Vertigo Patient by Indication
2.3 Global Treatable Vertigo Patient by Region
2.4 Global Treatable Vertigo Episodes by Region
2.5 Global Meniere's disease Market
2.5.1 Global Meniere's disease Patient Forecast
2.5.2 Global Meniere's disease Patient by Region
2.5.3 Global Otividex Drug Sales Forecast

3. Regional Market
3.1 Europe
3.1.1 Europe Recurrent Vestibular Vertigo Patient Forecast
3.1.2 Europe Treatable Vertigo Patient by Indication
3.1.3 Europe Meniere's Disease Patient Forecast
3.1.4 Europe Otividex Drug Sales Forecast
3.2 The US
3.2.1 The US Recurrent Vestibular Vertigo Patient Forecast
3.2.2 The US Treatable Vertigo Patient by Indication
3.2.3 The US Meniere's disease Patient Forecast
3.2.4 The US Meniere's Disease Patient Eligible for Steroid Injections
3.2.5 The US Otividex Sales Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Patient Population
4.1.2 Rising Geriatric Population
4.1.3 Increasing Healthcare Expenditure
4.1.4 Rising Disposable Income
4.2 Key Trends & Development
4.2.1 Extensive R&D Expenditure
4.2.2 Players Adopting Different Approaches for Drug Mechanism
4.3 Key Challenges
4.3.1 Hasty Drug Approval Process
4.3.2 Side Effects of the Current Therapies
4.3.3 High Cost

5. Competitive Landscape
5.1 Global Vertigo Market
5.1.1 Market Cap. Comparison by Companies
5.1.2 Product Comparison by Companies

6. Company Profiles

Explore more pharmaceuticals marketresearch as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Us:
Hrishikesh Patwardhan
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com

Media Contact: Hrishikesh Patwardhan, MarketReportsOnline, + 1 888 391 5441, sales@marketreportsonline.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE MarketReportsOnline



2017

Tags

Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Surveys, Polls and Research



Need Help